Global Biologics & Biosimilars Market 2018 - Cost Analysis, Revenue and Gross Margin Analysis with Its Important Types and Application

 Buy Now

   Published Date : Jun-2018   |    Format : PDF   |    Pages : 112
This report studies the global Biologics & Biosimilars market status and forecast, categorizes the global Biologics & Biosimilars market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Biologics & Biosimilars market is valued at  million US$ in 2017 and will reach  million US$ by the end of 2025, growing at a CAGR of  during 2018-2025.

The major players covered in this report
    fizer
    Roche
    Amgen
    AbbVie
    Sanofi
    Johnson & Johnson
    Novo Nordisk
    Novartis
    Merck
    Lilly
    3sbio
    Changchun High Tech
    CP Guojian Pharmacy
    Biotech Pharma
    Gelgen Biopharma
    Sandoz
    Teva
    Hospira
    Mylan

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    United States
    Europe
    China
    Japan
    Southeast Asia
    India

We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Rest of Asia-Pacific
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
        Rest of Europe
    Central & South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Saudi Arabia
        Turkey
        Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Antibiotic
    Enzyme
    Hormone
    Non-Patented Biological Reagents
    Other
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other

The study objectives of this report are:
    To analyze and study the global Biologics & Biosimilars sales, value, status (2013-2017) and forecast (2018-2025);
    To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
    Focuses on the key Biologics & Biosimilars players, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biologics & Biosimilars are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Biologics & Biosimilars Manufacturers
Biologics & Biosimilars Distributors/Traders/Wholesalers
Biologics & Biosimilars Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Biologics & Biosimilars market, by end-use.
Detailed analysis and profiles of additional market players.

Global Biologics & Biosimilars Sales Market Report 2018
1 Biologics & Biosimilars Market Overview
    1.1 Product Overview and Scope of Biologics & Biosimilars
    1.2 Classification of Biologics & Biosimilars by Product Category
        1.2.1 Global Biologics & Biosimilars Market Size (Sales) Comparison by Type (2013-2025)
        1.2.2 Global Biologics & Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 Antibiotic
        1.2.4 Enzyme
        1.2.5 Hormone
        1.2.6 Non-Patented Biological Reagents
        1.2.7 Other
    1.3 Global Biologics & Biosimilars Market by Application/End Users
        1.3.1 Global Biologics & Biosimilars Sales (Volume) and Market Share Comparison by Application (2013-2025)
        1.3.1 Tumor
        1.3.2 Diabetes
        1.3.3 Cardiovascular
        1.3.4 Hemophilia
        1.3.5 Other
    1.4 Global Biologics & Biosimilars Market by Region
        1.4.1 Global Biologics & Biosimilars Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 United States Biologics & Biosimilars Status and Prospect (2013-2025)
        1.4.3 Europe Biologics & Biosimilars Status and Prospect (2013-2025)
        1.4.4 China Biologics & Biosimilars Status and Prospect (2013-2025)
        1.4.5 Japan Biologics & Biosimilars Status and Prospect (2013-2025)
        1.4.6 Southeast Asia Biologics & Biosimilars Status and Prospect (2013-2025)
        1.4.7 India Biologics & Biosimilars Status and Prospect (2013-2025)
    1.5 Global Market Size (Value and Volume) of Biologics & Biosimilars (2013-2025)
        1.5.1 Global Biologics & Biosimilars Sales and Growth Rate (2013-2025)
        1.5.2 Global Biologics & Biosimilars Revenue and Growth Rate (2013-2025)

2 Global Biologics & Biosimilars Competition by Players/Suppliers, Type and Application
     2.1 Global Biologics & Biosimilars Market Competition by Players/Suppliers
        2.1.1 Global Biologics & Biosimilars Sales and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Global Biologics & Biosimilars Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Global Biologics & Biosimilars (Volume and Value) by Type
        2.2.1 Global Biologics & Biosimilars Sales and Market Share by Type (2013-2018)
        2.2.2 Global Biologics & Biosimilars Revenue and Market Share by Type (2013-2018)
    2.3 Global Biologics & Biosimilars (Volume and Value) by Region
        2.3.1 Global Biologics & Biosimilars Sales and Market Share by Region (2013-2018)
        2.3.2 Global Biologics & Biosimilars Revenue and Market Share by Region (2013-2018)
    2.4 Global Biologics & Biosimilars (Volume) by Application

3 United States Biologics & Biosimilars (Volume, Value and Sales Price)
    3.1 United States Biologics & Biosimilars Sales and Value (2013-2018)
        3.1.1 United States Biologics & Biosimilars Sales and Growth Rate (2013-2018)
        3.1.2 United States Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
        3.1.3 United States Biologics & Biosimilars Sales Price Trend (2013-2018)
    3.2 United States Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
    3.3 United States Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
    3.4 United States Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

4 Europe Biologics & Biosimilars (Volume, Value and Sales Price)
    4.1 Europe Biologics & Biosimilars Sales and Value (2013-2018)
        4.1.1 Europe Biologics & Biosimilars Sales and Growth Rate (2013-2018)
        4.1.2 Europe Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
        4.1.3 Europe Biologics & Biosimilars Sales Price Trend (2013-2018)
    4.2 Europe Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
    4.3 Europe Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
    4.4 Europe Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

5 China Biologics & Biosimilars (Volume, Value and Sales Price)
    5.1 China Biologics & Biosimilars Sales and Value (2013-2018)
        5.1.1 China Biologics & Biosimilars Sales and Growth Rate (2013-2018)
        5.1.2 China Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
        5.1.3 China Biologics & Biosimilars Sales Price Trend (2013-2018)
    5.2 China Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
    5.3 China Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
    5.4 China Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

6 Japan Biologics & Biosimilars (Volume, Value and Sales Price)
    6.1 Japan Biologics & Biosimilars Sales and Value (2013-2018)
        6.1.1 Japan Biologics & Biosimilars Sales and Growth Rate (2013-2018)
        6.1.2 Japan Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
        6.1.3 Japan Biologics & Biosimilars Sales Price Trend (2013-2018)
    6.2 Japan Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
    6.3 Japan Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
    6.4 Japan Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Biologics & Biosimilars (Volume, Value and Sales Price)
    7.1 Southeast Asia Biologics & Biosimilars Sales and Value (2013-2018)
        7.1.1 Southeast Asia Biologics & Biosimilars Sales and Growth Rate (2013-2018)
        7.1.2 Southeast Asia Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
        7.1.3 Southeast Asia Biologics & Biosimilars Sales Price Trend (2013-2018)
    7.2 Southeast Asia Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
    7.3 Southeast Asia Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
    7.4 Southeast Asia Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

8 India Biologics & Biosimilars (Volume, Value and Sales Price)
    8.1 India Biologics & Biosimilars Sales and Value (2013-2018)
        8.1.1 India Biologics & Biosimilars Sales and Growth Rate (2013-2018)
        8.1.2 India Biologics & Biosimilars Revenue and Growth Rate (2013-2018)
        8.1.3 India Biologics & Biosimilars Sales Price Trend (2013-2018)
    8.2 India Biologics & Biosimilars Sales Volume and Market Share by Players (2013-2018)
    8.3 India Biologics & Biosimilars Sales Volume and Market Share by Type (2013-2018)
    8.4 India Biologics & Biosimilars Sales Volume and Market Share by Application (2013-2018)

9 Global Biologics & Biosimilars Players/Suppliers Profiles and Sales Data
    9.1 fizer
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Biologics & Biosimilars Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 fizer Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.1.4 Main Business/Business Overview
    9.2 Roche
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Biologics & Biosimilars Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Roche Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.2.4 Main Business/Business Overview
    9.3 Amgen
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Biologics & Biosimilars Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Amgen Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.3.4 Main Business/Business Overview
    9.4 AbbVie
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Biologics & Biosimilars Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 AbbVie Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.4.4 Main Business/Business Overview
    9.5 Sanofi
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Biologics & Biosimilars Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Sanofi Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.5.4 Main Business/Business Overview
    9.6 Johnson & Johnson
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Biologics & Biosimilars Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Johnson & Johnson Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.6.4 Main Business/Business Overview
    9.7 Novo Nordisk
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Biologics & Biosimilars Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 Novo Nordisk Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.7.4 Main Business/Business Overview
    9.8 Novartis
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Biologics & Biosimilars Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Novartis Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.8.4 Main Business/Business Overview
    9.9 Merck
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Biologics & Biosimilars Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Merck Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.9.4 Main Business/Business Overview
    9.10 Lilly
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Biologics & Biosimilars Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Lilly Biologics & Biosimilars Sales, Revenue, Price and Gross Margin (2013-2018)
        9.10.4 Main Business/Business Overview
    9.11 3sbio
    9.12 Changchun High Tech
    9.13 CP Guojian Pharmacy
    9.14 Biotech Pharma
    9.15 Gelgen Biopharma
    9.16 Sandoz
    9.17 Teva
    9.18 Hospira
    9.19 Mylan

10 Biologics & Biosimilars Maufacturing Cost Analysis
    10.1 Biologics & Biosimilars Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Biologics & Biosimilars
    10.3 Manufacturing Process Analysis of Biologics & Biosimilars

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Biologics & Biosimilars Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Biologics & Biosimilars Major Manufacturers in 2017
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Biologics & Biosimilars Market Forecast (2018-2025)
    14.1 Global Biologics & Biosimilars Sales Volume, Revenue and Price Forecast (2018-2025)
       14.1.1 Global Biologics & Biosimilars Sales Volume and Growth Rate Forecast (2018-2025)
       14.1.2 Global Biologics & Biosimilars Revenue and Growth Rate Forecast (2018-2025)
       14.1.3 Global Biologics & Biosimilars Price and Trend Forecast (2018-2025)
    14.2 Global Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
       14.2.1 Global Biologics & Biosimilars Sales Volume and Growth Rate Forecast by Regions (2018-2025)
       14.2.2 Global Biologics & Biosimilars Revenue and Growth Rate Forecast by Regions (2018-2025)
       14.2.3 United States Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.4 Europe Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.5 China Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.6 Japan Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.7 Southeast Asia Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
       14.2.8 India Biologics & Biosimilars Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
    14.3 Global Biologics & Biosimilars Sales Volume, Revenue and Price Forecast by Type (2018-2025)
       14.3.1 Global Biologics & Biosimilars Sales Forecast by Type (2018-2025)
       14.3.2 Global Biologics & Biosimilars Revenue Forecast by Type (2018-2025)
       14.3.3 Global Biologics & Biosimilars Price Forecast by Type (2018-2025)
    14.4 Global Biologics & Biosimilars Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer
List of Tables and Figures

    Figure Product Picture of Biologics & Biosimilars
    Figure Global Biologics & Biosimilars Sales Volume Comparison (K Units) by Type (2013-2025)
    Figure Global Biologics & Biosimilars Sales Volume Market Share by Type (Product Category) in 2017
    Figure Antibiotic Product Picture
    Figure Enzyme Product Picture
    Figure Hormone Product Picture
    Figure Non-Patented Biological Reagents Product Picture
    Figure Other Product Picture
    Figure Global Biologics & Biosimilars Sales Comparison (K Units) by Application (2013-2025)
    Figure Global Sales Market Share of Biologics & Biosimilars by Application in 2017
    Figure Tumor Examples
    Table Key Downstream Customer in Tumor
    Figure Diabetes Examples
    Table Key Downstream Customer in Diabetes
    Figure Cardiovascular Examples
    Table Key Downstream Customer in Cardiovascular
    Figure Hemophilia Examples
    Table Key Downstream Customer in Hemophilia
    Figure Other Examples
    Table Key Downstream Customer in Other
    Figure Global Biologics & Biosimilars Market Size (Million USD) by Regions (2013-2025)
    Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Europe Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
    Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Biologics & Biosimilars Sales Volume (K Units) and Growth Rate (2013-2025)
    Figure Global Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Global Market Major Players Biologics & Biosimilars Sales Volume (K Units) (2013-2018)
    Table Global Biologics & Biosimilars Sales (K Units) of Key Players/Suppliers (2013-2018)
    Table Global Biologics & Biosimilars Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Biologics & Biosimilars Sales Share by Players/Suppliers
    Figure 2017 Biologics & Biosimilars Sales Share by Players/Suppliers
    Figure Global Biologics & Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Biologics & Biosimilars Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Global Biologics & Biosimilars Revenue Share by Players/Suppliers (2013-2018)
    Table 2017 Global Biologics & Biosimilars Revenue Share by Players
    Table 2017 Global Biologics & Biosimilars Revenue Share by Players
    Table Global Biologics & Biosimilars Sales (K Units) and Market Share by Type (2013-2018)
    Table Global Biologics & Biosimilars Sales Share (K Units) by Type (2013-2018)
    Figure Sales Market Share of Biologics & Biosimilars by Type (2013-2018)
    Figure Global Biologics & Biosimilars Sales Growth Rate by Type (2013-2018)
    Table Global Biologics & Biosimilars Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Global Biologics & Biosimilars Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Biologics & Biosimilars by Type (2013-2018)
    Figure Global Biologics & Biosimilars Revenue Growth Rate by Type (2013-2018)
    Table Global Biologics & Biosimilars Sales Volume (K Units) and Market Share by Region (2013-2018)
    Table Global Biologics & Biosimilars Sales Share by Region (2013-2018)
    Figure Sales Market Share of Biologics & Biosimilars by Region (2013-2018)
    Figure Global Biologics & Biosimilars Sales Growth Rate by Region in 2017
    Table Global Biologics & Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Biologics & Biosimilars Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Biologics & Biosimilars by Region (2013-2018)
    Figure Global Biologics & Biosimilars Revenue Growth Rate by Region in 2017
    Table Global Biologics & Biosimilars Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Global Biologics & Biosimilars Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Biologics & Biosimilars by Region (2013-2018)
    Figure Global Biologics & Biosimilars Revenue Market Share by Region in 2017
    Table Global Biologics & Biosimilars Sales Volume (K Units) and Market Share by Application (2013-2018)
    Table Global Biologics & Biosimilars Sales Share (%) by Application (2013-2018)
    Figure Sales Market Share of Biologics & Biosimilars by Application (2013-2018)
    Figure Global Biologics & Biosimilars Sales Market Share by Application (2013-2018)
    Figure United States Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
    Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
    Figure United States Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
    Table United States Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
    Table United States Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
    Figure United States Biologics & Biosimilars Sales Volume Market Share by Players in 2017
    Table United States Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
    Table United States Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
    Figure United States Biologics & Biosimilars Sales Volume Market Share by Type in 2017
    Table United States Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
    Table United States Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
    Figure United States Biologics & Biosimilars Sales Volume Market Share by Application in 2017
    Figure Europe Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
    Figure Europe Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Europe Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
    Table Europe Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
    Table Europe Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
    Figure Europe Biologics & Biosimilars Sales Volume Market Share by Players in 2017
    Table Europe Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
    Table Europe Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
    Figure Europe Biologics & Biosimilars Sales Volume Market Share by Type in 2017
    Table Europe Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
    Table Europe Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
    Figure Europe Biologics & Biosimilars Sales Volume Market Share by Application in 2017
    Figure China Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
    Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
    Table China Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
    Table China Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
    Figure China Biologics & Biosimilars Sales Volume Market Share by Players in 2017
    Table China Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
    Table China Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
    Figure China Biologics & Biosimilars Sales Volume Market Share by Type in 2017
    Table China Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
    Table China Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
    Figure China Biologics & Biosimilars Sales Volume Market Share by Application in 2017
    Figure Japan Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
    Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
    Table Japan Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
    Table Japan Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
    Figure Japan Biologics & Biosimilars Sales Volume Market Share by Players in 2017
    Table Japan Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
    Table Japan Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
    Figure Japan Biologics & Biosimilars Sales Volume Market Share by Type in 2017
    Table Japan Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
    Table Japan Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
    Figure Japan Biologics & Biosimilars Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
    Figure Southeast Asia Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
    Table Southeast Asia Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
    Table Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
    Figure Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Players in 2017
    Table Southeast Asia Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
    Table Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Type in 2017
    Table Southeast Asia Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
    Table Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Biologics & Biosimilars Sales Volume Market Share by Application in 2017
    Figure India Biologics & Biosimilars Sales (K Units) and Growth Rate (2013-2018)
    Figure India Biologics & Biosimilars Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Biologics & Biosimilars Sales Price (USD/Unit) Trend (2013-2018)
    Table India Biologics & Biosimilars Sales Volume (K Units) by Players (2013-2018)
    Table India Biologics & Biosimilars Sales Volume Market Share by Players (2013-2018)
    Figure India Biologics & Biosimilars Sales Volume Market Share by Players in 2017
    Table India Biologics & Biosimilars Sales Volume (K Units) by Type (2013-2018)
    Table India Biologics & Biosimilars Sales Volume Market Share by Type (2013-2018)
    Figure India Biologics & Biosimilars Sales Volume Market Share by Type in 2017
    Table India Biologics & Biosimilars Sales Volume (K Units) by Application (2013-2018)
    Table India Biologics & Biosimilars Sales Volume Market Share by Application (2013-2018)
    Figure India Biologics & Biosimilars Sales Volume Market Share by Application in 2017
    Table fizer Basic Information List
    Table fizer Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure fizer Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure fizer Biologics & Biosimilars Sales Global Market Share (2013-2018)
    Figure fizer Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Roche Basic Information List
    Table Roche Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Roche Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Roche Biologics & Biosimilars Sales Global Market Share (2013-2018)
    Figure Roche Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Amgen Basic Information List
    Table Amgen Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Amgen Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Amgen Biologics & Biosimilars Sales Global Market Share (2013-2018
    Figure Amgen Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table AbbVie Basic Information List
    Table AbbVie Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure AbbVie Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure AbbVie Biologics & Biosimilars Sales Global Market Share (2013-2018)
    Figure AbbVie Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Sanofi Basic Information List
    Table Sanofi Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Sanofi Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Sanofi Biologics & Biosimilars Sales Global Market Share (2013-2018)
    Figure Sanofi Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Johnson & Johnson Basic Information List
    Table Johnson & Johnson Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Johnson & Johnson Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Johnson & Johnson Biologics & Biosimilars Sales Global Market Share (2013-2018
    Figure Johnson & Johnson Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Novo Nordisk Basic Information List
    Table Novo Nordisk Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Novo Nordisk Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Novo Nordisk Biologics & Biosimilars Sales Global Market Share (2013-2018)
    Figure Novo Nordisk Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Novartis Basic Information List
    Table Novartis Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Novartis Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Novartis Biologics & Biosimilars Sales Global Market Share (2013-2018
    Figure Novartis Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Merck Basic Information List
    Table Merck Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Merck Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Merck Biologics & Biosimilars Sales Global Market Share (2013-2018)
    Figure Merck Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table Lilly Basic Information List
    Table Lilly Biologics & Biosimilars Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
    Figure Lilly Biologics & Biosimilars Sales Growth Rate (2013-2018)
    Figure Lilly Biologics & Biosimilars Sales Global Market Share (2013-2018)
    Figure Lilly Biologics & Biosimilars Revenue Global Market Share (2013-2018)
    Table 3sbio Basic Information List
    Table Changchun High Tech Basic Information List
    Table CP Guojian Pharmacy Basic Information List
    Table Biotech Pharma Basic Information List
    Table Gelgen Biopharma Basic Information List
    Table Sandoz Basic Information List
    Table Teva Basic Information List
    Table Hospira Basic Information List
    Table Mylan Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biologics & Biosimilars
    Figure Manufacturing Process Analysis of Biologics & Biosimilars
    Figure Biologics & Biosimilars Industrial Chain Analysis
    Table Raw Materials Sources of Biologics & Biosimilars Major Players in 2017
    Table Major Buyers of Biologics & Biosimilars
    Table Distributors/Traders List
    Figure Global Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Global Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Global Biologics & Biosimilars Price (USD/Unit) and Trend Forecast (2018-2025)
    Table Global Biologics & Biosimilars Sales Volume (K Units) Forecast by Regions (2018-2025)
    Figure Global Biologics & Biosimilars Sales Volume Market Share Forecast by Regions (2018-2025)
    Figure Global Biologics & Biosimilars Sales Volume Market Share Forecast by Regions in 2025
    Table Global Biologics & Biosimilars Revenue (Million USD) Forecast by Regions (2018-2025)
    Figure Global Biologics & Biosimilars Revenue Market Share Forecast by Regions (2018-2025)
    Figure Global Biologics & Biosimilars Revenue Market Share Forecast by Regions in 2025
    Figure United States Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure United States Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Europe Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Europe Biologics & Biosimilars Revenue and Growth Rate Forecast (2018-2025)
    Figure China Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure China Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Biologics & Biosimilars Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
    Figure Japan Biologics & Biosimilars Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Biologics & Biosim



Latest News

25-Feb-2019 | Chemicals & Materials

Industrial Alliance To Help Waste Management Market To Rise

An alliance of 28 large companies has launched a global organization to find solutions to remove plastic waste from the environment. The Alliance for the Disposal of Plastic Waste (AEPW), which collaborates with the World Business Council for Sustainable Development (WBCSD), brings together chemical and plastic companies as well as consumer goods companies.

25-Feb-2019 | Electrical & Electronic Device

Insights Into Fish’s Swimming Adds Sensory Feedback Feature To Global Robotics Market

The fish have a random movement with excellent sensory feedback so as to help them navigate the world. According to the Johns Hopkins University researchers, the inclusion of this movement in understanding the active sensing behaviors of animals can actually help advance the robotic platform in terms of medical, industrial, defense, and commercial sectors. The sensors can help improve the inter ...

13-Feb-2019 | Technology

Battle Between Apple And Qualcomm Likely To Impact The Growth Of The Smartphone Market

The smartphone market has observed a tremendous transformation owing to advancement in technology, better services, the advent of 4G & 5G networks, and so on. Recently, Qualcomm Inc had filed a patent lawsuit against Apple Inc that imposed a veto on sales of few iPhone devices in Germany. This, certainly, was expected to pose a negative impact on the growth of the smartphone market in that ...

13-Feb-2019 | Food & Beverage

Belizean Turmeric Gets Place in Global Turmeric Market

A novel product manufactured from Belizean-grown turmeric has started to hit the shelves of grocery stores in Belize as well as in Canada. The latest product is supposed to catch the turmeric market in the rest of the Caribbean as well. This budge is supposed to offer novel opportunities to farmers as well as agro-processors in the Toledo district. Till date, more than 350 turmeric cultivators ...

05-Feb-2019 | Automobile

Automotive Mobility Market Growth Has A Handle On New AEye Product Sale

The automotive mobility market will be skyrocketing by this year as AEye, which is one of the world’s best artificial perception systems and the maker of iDAR has recently declared that it will be launching the AE110. The new technology has been built on the highly wide-ranging solid-state LiDAR patent portfolio. The AE110 is the only one possessing the firm's solitary software-linked ...